Want to join the conversation?
$AMGN's pivotal Phase 3 head-to-head ENDEAVOR study results published in The Lancet Oncology demonstrate superiority of Kyprolis (carfilzomib) combination over Velcade (bortezomib) in patients with relapsed multiple myeloma, which is a cancer that forms in a type of white blood cell called a plasma cell.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.